A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia - Gacci, M; Corona, G; Salvi, M (Eur Urol, 2012)
et al.